Aziz Ismail Shaibani MD ,FACP, FAAN, FANA

Neurology•Houston, TX

Neuromuscular Medicine, Neurophysiology

Clinical Professor of Medicine, Baylor College of Medicine

Join to View Full Profile

6624 Fannin StSuite 1670Houston, TX 77030
Phone+1 713-795-0033
Fax+1 713-796-9302

Summary

nerveandmuscle.org

Education & Training

Baylor College of MedicineFellowship, Clinical Neurophysiology, 1995
Baylor College of MedicineResidency, Neurology, 1991 - 1994
Conemaugh Memorial Medical CenterInternship, Transitional Year, 1990 - 1991
University of Mosul College of MedicineClass of 1983

Certifications & Licensure

TX State Medical License 1993 - 2025
UT State Medical License 1992 - 1994
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Super Doctor SuperDoctors.com

Clinical Trials

Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy Start of enrollment: 2006 Jun 01
Completed
Phase 3
Efficacy of Methotrexate in Myasthenia Gravis Start of enrollment: 2009 Apr 01
Completed
Phase 2
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy Start of enrollment: 2014 Mar 01
Completed
Phase 2
Therapy in Amyotrophic Lateral Sclerosis (TAME) Start of enrollment: 2018 Nov 07
Completed
Phase 2
A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy Start of enrollment: 2014 Jun 01
Completed
Phase 2
The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy Start of enrollment: 2015 Dec 01
Completed
Phase 2
An Efficacy and Safety Study of Ravulizumab in ALS Participants Start of enrollment: 2020 Mar 30
Terminated
Phase 3
Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy Start of enrollment: 2020 Nov 20
COMPLETED
PHASE3
Myasthenia Gravis Inebilizumab Trial Start of enrollment: 2020 Oct 15
ACTIVE_NOT_RECRUITING
PHASE3
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis Start of enrollment: 2021 Dec 14
RECRUITING
PHASE3
Roles: Principal Investigator, Contact
Study of M5049 in DM and PM Participants (NEPTUNIA) Start of enrollment: 2023 Jan 19
RECRUITING
PHASE2
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Placebo nonresponders: An experimental investigation on their unreliability over time.
Fabrizio Benedetti, Wilma Thoen, Aziz Shaibani, Claudia Arduino
The Journal of Pain. 2025-03-01
1 citations
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial.
Rohit Aggarwal, Ingrid E Lundberg, Yeong-Wook Song, Aziz Shaibani, Victoria P Werth
Arthritis & Rheumatology. 2024-11-28
1 citations
The impact of patients' pre-treatment expectations on immunosuppressive treatment outcomes in myasthenia gravis: A pilot correlational study.
Elisa Frisaldi, Bruno Ferrero, Alessandra Di Liberto, Diletta Barbiani, Eleonora Maria Camerone
Muscle & Nerve. 2024-09-01

Press Mentions

A Lonestar Tick Bite Could Cause Red Meat AllergyJuly 18th, 2018

Professional Memberships

American Academy of Neurology - AAN
Member